Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Boris B. Boyanovsky"'
Autor:
Boris B. Boyanovsky
Publikováno v:
Journal of Cardiovascular Pharmacology.
Autor:
Samuel Kadavakollu, Krista S. Lund, Varsha Swamy, William D. Kim, Ronald A. Llenado, Taylor F. Nunes, Mahboob Qureshi, John W. Graneto, Boris B. Boyanovsky
Publikováno v:
Journal of osteopathic medicineReferences. 122(11)
Context Premedical preparatory programs at osteopathic medical schools that recruit students from medically underserved areas (MUAs) may promote interest in practicing osteopathic medicine in underserved or rural areas. In these programs, emphasis on
Autor:
Boris B. Boyanovsky, Preetha Shridas, Michael Simons, Deneys R. van der Westhuyzen, Nancy R. Webb
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 4, Pp 641-650 (2009)
We previously reported that LDL modified by group V secretory phospholipase A2 (GV-LDL) promotes macrophage foam cell formation through a mechanism independent of scavenger receptors SR-A and CD36, and dependent on cellular proteoglycans. This study
Externí odkaz:
https://doaj.org/article/3fcfd78dd8464d5095217babb98b612b
Autor:
Bing Sun, Boris B. Boyanovsky, Margery A. Connelly, Preetha Shridas, Deneys R. van der Westhuyzen, Nancy R. Webb
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 12, Pp 2560-2570 (2007)
Modified forms of LDL, including oxidized low density lipoprotein (OxLDL), contribute to macrophage lipid accumulation in the vessel wall. Despite the pathophysiological importance of uptake pathways for OxLDL, the molecular details of OxLDL endocyto
Externí odkaz:
https://doaj.org/article/67dddbcdee3a4d2faf9756f64d64df49
Autor:
William M. Bailey, Michael H. Gelb, Boris B. Boyanovsky, Preetha Shridas, Rob C. Oslund, Nancy R. Webb
Publikováno v:
Journal of Biological Chemistry. 285:20031-20039
We developed C57BL/6 mice with targeted deletion of group X secretory phospholipase A(2) (GX KO). These mice have approximately 80% higher plasma corticosterone concentrations compared with wild-type (WT) mice under both basal and adrenocorticotropic
Autor:
Nancy R. Webb, Manjula Sunkara, Preetha Shridas, Xia Li, Andrew J. Morris, Boris B. Boyanovsky
Publikováno v:
Cytokine. 50:50-57
Objective: Previous studies have established that hydrolysis of LDL by Group V secretory phospholipase A 2 (GV sPLA 2 ) generates a modified particle capable of inducing macrophage foam cell formation. The aim of the present study was to determine wh
Autor:
Michael Simons, Deneys R. van der Westhuyzen, Nancy R. Webb, Boris B. Boyanovsky, Preetha Shridas
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 4, Pp 641-650 (2009)
We previously reported that LDL modified by group V secretory phospholipase A2 (GV-LDL) promotes macrophage foam cell formation through a mechanism independent of scavenger receptors SR-A and CD36, and dependent on cellular proteoglycans. This study
Autor:
Michael B. Reid, Alfred H. Merrill, Krassimira A. Rozenova, Melissa A. Chambers, Jia Wei, Boris B. Boyanovsky, James White, Alan Daugherty, Eric J. Smart, Natalia V. Giltiay, Mariana Nikolova-Karakashian, Gergana M. Deevska
Publikováno v:
Journal of Biological Chemistry. 284:8359-8368
Acid sphingomyelinase plays important roles in ceramide homeostasis, which has been proposed to be linked to insulin resistance. To test this association in vivo, acid sphingomyelinase deletion (asm–/–) was transferred to mice lacking the low den
Autor:
Marilyn P. Wadsworth, Boris B. Boyanovsky, Frederick C. de Beer, Meredith A. Bostrom, Craig T. Jordan, Douglas J. Taatjes, Nancy R. Webb
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 27:600-606
Objective— Group V secretory phospholipase A 2 (GV sPLA 2 ) has been detected in both human and mouse atherosclerotic lesions. This enzyme has potent hydrolytic activity towards phosphatidylcholine-containing substrates, including lipoprotein parti
Publikováno v:
Journal of Biological Chemistry. 280:32746-32752
Accumulating evidence indicates that secretory phospholipase A2 (sPLA2) enzymes promote atherogenic processes. We have previously showed the presence of Group V sPLA2 (GV sPLA2) in human and mouse atherosclerotic lesions, its hydrolysis of low densit